Incidental Mutation 'R5519:Padi2'
ID 431453
Institutional Source Beutler Lab
Gene Symbol Padi2
Ensembl Gene ENSMUSG00000028927
Gene Name peptidyl arginine deiminase, type II
Synonyms Pdi2, Pdi, PAD type II
MMRRC Submission 043078-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.129) question?
Stock # R5519 (G1)
Quality Score 225
Status Not validated
Chromosome 4
Chromosomal Location 140633655-140679897 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 140676533 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Aspartic acid to Glycine at position 557 (D557G)
Ref Sequence ENSEMBL: ENSMUSP00000030765 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000030765]
AlphaFold Q08642
Predicted Effect probably damaging
Transcript: ENSMUST00000030765
AA Change: D557G

PolyPhen 2 Score 0.996 (Sensitivity: 0.55; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000030765
Gene: ENSMUSG00000028927
AA Change: D557G

DomainStartEndE-ValueType
Pfam:PAD_N 9 122 1.7e-36 PFAM
Pfam:PAD_M 124 282 4e-71 PFAM
Pfam:PAD 292 670 3.8e-174 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000130958
Predicted Effect noncoding transcript
Transcript: ENSMUST00000140501
Coding Region Coverage
  • 1x: 99.1%
  • 3x: 97.6%
  • 10x: 94.7%
  • 20x: 88.5%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. The type II enzyme is the most widely expressed family member. Known substrates for this enzyme include myelin basic protein in the central nervous system and vimentin in skeletal muscle and macrophages. This enzyme is thought to play a role in the onset and progression of neurodegenerative human disorders, including Alzheimer disease and multiple sclerosis, and it has also been implicated in glaucoma pathogenesis. This gene exists in a cluster with four other paralogous genes. [provided by RefSeq, Jul 2008]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit impaired ATP- or calcium ionophore ionomycin-induced citrullination of mast cells or of proteins following induction of EAE. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 36 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
1700067K01Rik T C 8: 84,729,621 (GRCm39) V99A possibly damaging Het
2510009E07Rik A G 16: 21,472,218 (GRCm39) S91P probably benign Het
2810021J22Rik G A 11: 58,770,923 (GRCm39) S135N probably benign Het
A530084C06Rik T C 13: 31,742,702 (GRCm39) probably benign Het
Acadsb T C 7: 131,031,694 (GRCm39) S177P probably damaging Het
Acp3 C A 9: 104,168,687 (GRCm39) G393W probably damaging Het
Axl G A 7: 25,478,087 (GRCm39) A204V possibly damaging Het
Birc6 A T 17: 74,887,173 (GRCm39) M806L probably benign Het
Cacna1i T C 15: 80,255,700 (GRCm39) L861P probably damaging Het
Cfap44 A T 16: 44,224,451 (GRCm39) D53V probably damaging Het
Col9a1 G A 1: 24,269,335 (GRCm39) probably null Het
Ctf2 T A 7: 127,318,463 (GRCm39) I179L probably benign Het
Cybb C G X: 9,316,989 (GRCm39) D246H probably benign Het
Emilin2 G A 17: 71,559,930 (GRCm39) P1016S probably benign Het
Gm12790 G A 4: 101,824,888 (GRCm39) P127S probably benign Het
Gsap T A 5: 21,494,857 (GRCm39) V24E probably damaging Het
Ipp T C 4: 116,367,964 (GRCm39) F66L possibly damaging Het
Jakmip3 T C 7: 138,609,520 (GRCm39) I208T probably damaging Het
Med30 G T 15: 52,584,462 (GRCm39) D127Y probably damaging Het
Mosmo C T 7: 120,329,733 (GRCm39) P118L probably benign Het
Ncam2 C T 16: 81,231,766 (GRCm39) R77* probably null Het
Nfkb2 G T 19: 46,296,006 (GRCm39) E170D probably benign Het
Or51a42 G A 7: 103,708,504 (GRCm39) Q102* probably null Het
Pde11a T A 2: 75,906,299 (GRCm39) K639N probably damaging Het
Pspc1 T C 14: 57,009,413 (GRCm39) I140M probably benign Het
Rundc3a A T 11: 102,292,857 (GRCm39) I417F probably benign Het
Scn1a T A 2: 66,162,557 (GRCm39) I230F probably damaging Het
Serpinb3b A G 1: 107,087,506 (GRCm39) M1T probably null Het
Sin3a T C 9: 57,025,457 (GRCm39) probably null Het
St8sia1 T C 6: 142,909,287 (GRCm39) N70D probably damaging Het
Tdpoz4 A T 3: 93,704,806 (GRCm39) T368S probably benign Het
Tpm2 T G 4: 43,522,751 (GRCm39) D55A possibly damaging Het
Trdv1 T A 14: 54,119,405 (GRCm39) M22K probably benign Het
Zc3h4 A T 7: 16,169,157 (GRCm39) T1089S unknown Het
Zfp518b G A 5: 38,831,441 (GRCm39) T188M probably damaging Het
Zfp74 G T 7: 29,634,559 (GRCm39) A383D probably damaging Het
Other mutations in Padi2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01311:Padi2 APN 4 140,644,948 (GRCm39) missense probably benign 0.27
IGL01374:Padi2 APN 4 140,660,496 (GRCm39) missense probably damaging 1.00
IGL01608:Padi2 APN 4 140,659,541 (GRCm39) missense probably damaging 1.00
IGL02085:Padi2 APN 4 140,654,468 (GRCm39) nonsense probably null
IGL02593:Padi2 APN 4 140,677,153 (GRCm39) missense probably damaging 1.00
IGL02668:Padi2 APN 4 140,677,191 (GRCm39) missense probably benign 0.02
IGL03341:Padi2 APN 4 140,654,424 (GRCm39) missense probably benign 0.06
R0116:Padi2 UTSW 4 140,653,550 (GRCm39) missense probably benign 0.00
R2045:Padi2 UTSW 4 140,665,241 (GRCm39) missense probably damaging 1.00
R2079:Padi2 UTSW 4 140,660,507 (GRCm39) missense probably damaging 1.00
R3022:Padi2 UTSW 4 140,665,299 (GRCm39) missense possibly damaging 0.79
R3079:Padi2 UTSW 4 140,677,189 (GRCm39) missense probably damaging 0.99
R3780:Padi2 UTSW 4 140,645,048 (GRCm39) missense probably benign 0.00
R4250:Padi2 UTSW 4 140,633,857 (GRCm39) missense probably damaging 0.97
R4276:Padi2 UTSW 4 140,663,859 (GRCm39) missense possibly damaging 0.93
R4647:Padi2 UTSW 4 140,671,757 (GRCm39) missense probably damaging 1.00
R5058:Padi2 UTSW 4 140,659,432 (GRCm39) missense probably benign 0.00
R5452:Padi2 UTSW 4 140,659,382 (GRCm39) missense probably benign 0.26
R5471:Padi2 UTSW 4 140,660,519 (GRCm39) missense possibly damaging 0.90
R5489:Padi2 UTSW 4 140,671,799 (GRCm39) missense probably damaging 0.99
R5666:Padi2 UTSW 4 140,676,542 (GRCm39) missense possibly damaging 0.76
R5793:Padi2 UTSW 4 140,660,501 (GRCm39) missense probably benign 0.04
R5913:Padi2 UTSW 4 140,644,952 (GRCm39) missense probably benign 0.00
R5929:Padi2 UTSW 4 140,671,848 (GRCm39) critical splice donor site probably null
R5933:Padi2 UTSW 4 140,644,952 (GRCm39) missense probably benign 0.00
R6478:Padi2 UTSW 4 140,644,948 (GRCm39) missense probably benign 0.00
R6809:Padi2 UTSW 4 140,674,077 (GRCm39) splice site probably null
R7075:Padi2 UTSW 4 140,660,528 (GRCm39) missense probably damaging 0.96
R7313:Padi2 UTSW 4 140,660,079 (GRCm39) missense probably damaging 0.99
R7380:Padi2 UTSW 4 140,644,997 (GRCm39) nonsense probably null
R7391:Padi2 UTSW 4 140,665,266 (GRCm39) missense probably benign 0.01
R7574:Padi2 UTSW 4 140,676,648 (GRCm39) missense possibly damaging 0.87
R7776:Padi2 UTSW 4 140,651,656 (GRCm39) missense probably benign 0.01
R7791:Padi2 UTSW 4 140,644,907 (GRCm39) missense probably benign 0.00
R7810:Padi2 UTSW 4 140,676,575 (GRCm39) missense possibly damaging 0.91
R7985:Padi2 UTSW 4 140,659,403 (GRCm39) missense probably benign 0.06
R8154:Padi2 UTSW 4 140,651,620 (GRCm39) splice site probably null
R8481:Padi2 UTSW 4 140,660,564 (GRCm39) missense probably benign 0.01
R8524:Padi2 UTSW 4 140,677,006 (GRCm39) missense possibly damaging 0.90
R8732:Padi2 UTSW 4 140,660,590 (GRCm39) missense probably benign 0.29
R9010:Padi2 UTSW 4 140,663,924 (GRCm39) missense probably damaging 0.99
R9653:Padi2 UTSW 4 140,662,036 (GRCm39) critical splice donor site probably null
Z1177:Padi2 UTSW 4 140,677,038 (GRCm39) missense probably damaging 1.00
Z1177:Padi2 UTSW 4 140,651,646 (GRCm39) missense possibly damaging 0.50
Predicted Primers PCR Primer
(F):5'- TAGCTGTGCCTCAAGTCAC -3'
(R):5'- AGGTTACCCAGCAACTCAGC -3'

Sequencing Primer
(F):5'- AATCTCTGTGAGTTCAAGGCCAG -3'
(R):5'- AACTCAGCTGGGCCCTTCTG -3'
Posted On 2016-10-05